Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Oct
25
2018
Top International News in Chemical Policy and Regulation: October 25, 2018: OECD, Asia, Americas and Middle East Bergeson & Campbell, P.C.
Oct
25
2018
Top International News in Chemical Policy and Regulation: October 25, 2018: European Union and United Kingdom Bergeson & Campbell, P.C.
Oct
25
2018
Proposed Amendments to Proposition 65 Regulations on Calculating Level of Exposure to Chemicals Causing Reproductive Toxicity; California Extends Comment Period Keller and Heckman LLP
Oct
25
2018
New Handbook Provides Guidance to Healthcare Delivery Organizations on Preparation and Response to Medical Device Cybersecurity Incidents Faegre Drinker
Oct
25
2018
The Feds and New York Allow Further Access to CBD and Medical Cannabis Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
25
2018
President Signs New Law Allowing Telemedicine Prescribing of Controlled Substances: DEA Special Registration to Go Live Foley & Lardner LLP
Oct
24
2018
New NJ Bill Aims to End Craft Brewery Tours & Add Food Vendors Stark & Stark
Oct
24
2018
FDA Emphasizes Continued Commitment to Develop a Strong Tobacco Product Application Review Process Keller and Heckman LLP
Oct
23
2018
WV Opioid Reduction Act Imposes New Restrictions and Responsibilities on Prescribers Steptoe & Johnson PLLC
Oct
23
2018
Six Initiatives States May Pursue to Curb Drug Prices and the 340B Factor Mintz
Oct
23
2018
China Announces Draft and Final Approvals for Food-Contact Materials Keller and Heckman LLP
Oct
23
2018
CMS Unveils Proposed Rule Regarding Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products Epstein Becker & Green, P.C.
Oct
23
2018
FDA Issues Draft Guidance on Produce Safety Requirements under FSMA Keller and Heckman LLP
Oct
22
2018
The European Commission finds no illegal State aid was provided by Luxembourg’s non-taxation of McDonald’s Covington & Burling LLP
Oct
22
2018
Ostroff Retires as FDA Deputy Commissioner for Foods and Vet Medicine; FDA to Undergo Food Safety Reorganization Keller and Heckman LLP
Oct
20
2018
The “Beef” With Plant Based “Meat” Product Labels Bilzin Sumberg
Oct
20
2018
NNI Publishes Key Takeaways and Transcript for Webinar on Technology Pathways Toward Commercializing Nanotechnology Bergeson & Campbell, P.C.
Oct
20
2018
Defense Victory in Product Labeling Class Action Bilzin Sumberg
Oct
19
2018
New Federal Laws Banning “Gag Clauses” in the Pharmacy Epstein Becker & Green, P.C.
Oct
19
2018
Further CBP Guidance on Craft Beverage Modernization Act McDermott Will & Emery
Oct
19
2018
CPSC Steps Up Enforcement of Child-Resistant Packaging Requirements Keller and Heckman LLP
Oct
19
2018
Looking Ahead: Proposed Regulatory Actions by FDA and USDA in the Fall 2018 Unified Agenda Keller and Heckman LLP
Oct
19
2018
New California Law Aims to Increase PBM Disclosure and Transparency Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
18
2018
California Appeals Court Grants Stay in Starbucks’ Proposition 65 Civil Penalties Trial Keller and Heckman LLP
Oct
17
2018
FDA's Drug Centers Release New Draft Guidance on Quantitative Info in Consumer-Directed Ads Mintz
Oct
17
2018
Trump Administration Proposes Requiring Disclosure of Drug Prices in TV Ads Mintz
Oct
17
2018
EPA Proposes SNURs that Break New Ground under Amended TSCA Bergeson & Campbell, P.C.
Oct
17
2018
FDA Sued for Failure to Implement “High-Risk” FSMA Provisions by the Statutory Deadlines Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins